FDA OPDP Sends First Untitled Letter of 2020 Thomas Sullivan Sep 16, 2020 0 This year has been a very slow year for enforcement letters from the United States Food and Drug Administration (FDA) Office of…
Congress House Oversight Committee Subpoenas AbbVie in Drug Pricing Probe Thomas Sullivan Sep 15, 2020 0 On September 1, 2020, Carolyn B. Maloney, Chairwoman of the United States House of Representatives Committee on Oversight and…
HHS-OIG HHS OIG Report Finds Opioid Use Decreasing on Medicare Part D Thomas Sullivan Sep 14, 2020 0 Earlier this year, the Department of Health and Human Services Office of Inspector General (HHS-OIG) completed a report in which…
COVID-19 Drug Pricing Policy Update – Election Uncertainty & Questions about… Thomas Sullivan Sep 11, 2020 0 As the current pandemic continues to dominate the current news cycle, the high costs of drugs remains an important issue for the…
Technology Numerof & Associates Releases Its Fifth Annual Study on Population… Thomas Sullivan Sep 10, 2020 0 Recently, Numerof & Associates released its fifth-annual study of United States population health. The report provides an…
CMS CMS 2021 Proposed Physician Fee Schedule – Updates to Telehealth,… Thomas Sullivan Sep 9, 2020 0 The Centers for Medicare & Medicaid Services (CMS) released the CY 2021 Revisions to Payment Policies under the Physician Fee…
Anti Kickback Individual NextHealth Marketer Indicted in $60 Million Kickback Scheme Thomas Sullivan Sep 8, 2020 0 On August 18, 2020, healthcare marketer Vinson Woodlee was indicted on one count of conspiracy to pay and receive healthcare…
Pharmaceutical and Device New Research Paper Indicates Price Transparency May Not Equate to Lower… Thomas Sullivan Sep 4, 2020 0 Last June, President Donald Trump signed an Executive Order on Improving Price and Quality Transparency in American Healthcare to…
CMS CMS Proposes New Coverage Pathway for Medical Devices Thomas Sullivan Sep 3, 2020 0 On August 31, 2020, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule that would create a new pathway…
Drug Prices Bausch Health (FKA Valeant Pharmaceuticals) Agrees to $45 Million SEC… Thomas Sullivan Sep 2, 2020 0 Earlier this year, the United States Securities and Exchange Commission (SEC) announced a settlement with Bausch Health (formerly…